New initiative to investigate the science underlying food allergy
22 June 2016 • Author(s): Victoria White, Digital Content Producer
The Food Allergy Science Initiative (FASI), which will be centred at the Broad, will tap the combined resources of participating academic and research institutions to help answer key scientific questions surrounding food allergies, the causes of which remain little-understood.
Commenting on the new initiative, Ruslan Medzhitov said: “We are bringing together scientists from several disciplines to tackle head on the underlying biology of food allergy. We believe that the combined scale of our approach will help to transform this field and open up new avenues for treatment and prevention.”
Many children suffer from debilitating food allergies, and much remains unknown about the root causes of the condition. Genetics, gut microbes, the immune system, and food-derived allergens—and the interactions between these factors—somehow lead to the breakdown in tolerance that drives food allergy, but we understand little about what leads to food allergy, how to prevent it, and how to resolve it once it arises.
However, with the dramatic advances in genomic technologies, immunology, and microbiome research in the past decade, scientists are now in a unique position to explore the biological mechanisms behind food allergies. Among the cutting-edge technologies the Broad will bring to bear on food allergy research are single-cell genomic analysis—which will reveal new information about the cell populations involved in the allergic response—and CRISPR genome-editing techniques, which will enable large-scale screens to test the role individual genes play in food allergy.
Too little known about food allergies
“There has been an urgent call for answers within the food allergy advocacy community, and a lot of great work is already underway,” says Aviv Regev. “However, we know too little about the basic biological mechanisms that underlie these allergies. We believe that with an ambitious, interdisciplinary approach, and a partnership between immunologists, clinicians, technologists, and computational scientists we can help speed research and enhance scientific understanding of food allergy in a manner that would translate in the future to improved diagnostics and therapies.”
The researchers enter a near-barren landscape in terms of our understanding of the fundamental biological mechanisms underlying food allergy. Currently, diagnosing and treating food allergy is a major challenge: allergic reactions, which can be life-threatening, are the primary means of diagnosis, and treatment is limited to avoidance of known allergy-causing foods and epinephrine injections, which are only administered once an allergic reaction has been triggered. Understanding the basic biology that drives the allergic response to food is a first step needed to catalyse research.
FASI aims to accelerate the pace of discovery in this field and enable the development of new diagnostics and treatments through a coordinated effort that brings together specialists from a variety of disciplines including immunology, gastroenterology, computational biology, molecular biology, and bioengineering to answer fundamental questions pertaining to food allergy.
ABF Ingredients ANDEROL EUROPE BV Avantes Berndorf Band GmbH BIOTECON Diagnostics GmbH Cargo Oil AB Elea GmbH Engilico FUCHS LUBRITECH GmbH GLOBALG.A.P. Foodplus GmbH InS Services (UK) Ltd IONICON Analytik GmbH JAX INC. JBT Corporation LUBRIPLATE Lubricants Company NSF International Ocean Optics PCE Instruments UK Ltd R-Biopharm Rhone Ltd Stancold SteriBeam The Tintometer® Group Thermo Fisher Scientific TOMRA Sorting Food Uhde High Pressure Technologies GmbH Verner Wheelock Vikan UK Ltd